Safety and efficacy of eltrombopag in patients with post-CAR T cytopenias.
William WessonNausheen AhmedAliya RashidCarine TabakEmerson LoganJose Marchena-BurgosMaggie NelsonJames A DavisMary McGannLeyla ShuneMarc HoffmannAl-Ola AbdallahHamza HashmiPublished in: European journal of haematology (2023)
The use of eltrombopag for post-CAR T leukopenia and thrombocytopenia was considered safe without any significant toxicities. The use of eltrombopag for post-CAR T cytopenias might be effective in a high-risk patient population but requires further study.
Keyphrases